Why Aegerion Pharmaceuticals, Bank of America and Three Other Stocks are in Spotlight Today?
Markets opened higher on Wednesday as investors await the announcement regarding interest rate hike from the Federal Reserve today.
Aegerion Pharmaceuticals Inc. (AEGR)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.75 | 75,000 | $131,250.00 | 4,361,291 | 2016-09-13 | Filing | |
| $1.70 | 76,000 | $129,200.00 | 4,286,291 | 2016-09-12 | Filing | |
| $1.70 | 100,000 | $169,600.00 | 4,210,291 | 2016-09-12 | Filing | |
| $1.60 | 100,000 | $159,500.00 | 4,110,291 | 2016-09-09 | Filing | |
| $10.96 | 35,000 | $383,600.00 | 4,010,291 | 2015-11-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.90 | 1,171 | $51,406.90 | 0 | 2014-04-30 | Filing | |
| $43.18 | 1,079 | $46,591.22 | 1,171 | 2014-04-30 | Filing | |
| $47.20 | 100 | $4,720.00 | 0 | 2014-03-31 | Filing | |
| $46.51 | 1,001 | $46,556.51 | 100 | 2014-03-31 | Filing | |
| $45.84 | 1,149 | $52,670.16 | 1,101 | 2014-03-31 | Filing |
Institutional Investors' Holdings
News See All
Sarissa Capital Management and Aegerion Pharmaceuticals, Inc. (AEGR) Amend Nomination Agreement
In a recent filing with the US Securities and Exchange Commission, Alex Denner's Sarissa Capital Management has reported entering into an amendment to the nomination agreement with Aegerion Pharmaceuticals...
Pharmaceutical And LNG Stocks Are Driving The Market Higher Today
U.S. stocks look set to end today's trading session in green territory, having gone through a strong selloff last week.
These Four Stocks Are Leading Today's Losers Pack for Various Reasons
Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red.
Aegerion Pharmaceuticals, Inc. (AEGR): Sarissa Capital Management Files Amended 13D
Sarissa Capital Management filed an amended 13D today regarding Aegerion Pharmaceuticals (NASDAQ:AEGR) disclosing the confidentiality agreement between the activist hedge fund and the pharmaceuticals ...
One Fund is Buying This Biotech Stock Although It's Losing Smart Money's Support
Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company.
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler's Broadfin Capital has initiated a stake in ContraFect Corp (NASDAQ:CFRX) to the tune of 1.42 million shares...
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector
At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with the Securities and Exchange Commission on a daily...
Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors
Kevin Kotler's New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR).
Hedge Fund Resource Center